Pharmaceutical Patents Under Threat

BMI is poised to downgrade Venezuela's score for intellectual property on our Pharmaceuticals & Healthcare Business Environment Ratings. The South American country is considering annulling patents on certain medicines and encouraging local manufacturers to make the drugs, instead of foreign multinationals. If the plan materialises, the score would be reduced from one to zero, a shocking grade that is unparalleled in BMI's 71-market coverage universe.

To read the full article, please choose one of the following options: